Market revenue in 2023 | USD 99.7 million |
Market revenue in 2030 | USD 113.2 million |
Growth rate | 1.8% (CAGR from 2023 to 2030) |
Largest segment | Controls |
Fastest growing segment | Calibrators |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Controls, Calibrators |
Key market players worldwide | Siemens Healthineers AG ADR, Abbott Laboratories, Bio-Rad Laboratories Inc, Danaher Corp, Roche Holding AG ADR, Sysmex Corp, QuidelOrtho Corp, Thermo Fisher Scientific Inc, BD, Merck KGaA, Qiagen NV, Hologic Inc, Bio-Techne Corp, Randox, Helena Laboratories, Seracare Life Sciences, Fortress Diagnostics, Microbiologics, TRINA BIOREACTIVES, Cone Bioproducts, Biorex Food Diagnostics |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to in vitro diagnostics quality control market will help companies and investors design strategic landscapes.
Controls was the largest segment with a revenue share of 48.35% in 2023. Horizon Databook has segmented the Canada in vitro diagnostics quality control market based on controls, calibrators covering the revenue growth of each sub-segment from 2018 to 2030.
The market in Canada is expected to grow at a lucrative rate over the forecast period. This high growth can be attributed to the increasing healthcare expenditure and expanding diagnostic industry in the country, which is expected to fuel the demand for quality control products for evaluation of clinical diagnostic products.
Furthermore, extensive R&D initiatives being undertaken by local players for infectious diseases and cancer as a result of continuous publicprivate funding are anticipated to create lucrative opportunities for IVD quality control products in the country.
In addition, increasing government initiatives to provide highly specialized infrastructure for diagnostic applications are also anticipated to fuel the demand for IVD quality control in the country. Usage of IVD devices in the country is increasing due to the rising prevalence of target diseases; rapid diagnosis, leading to better treatment alternatives; and presence of a health-conscious population.
Horizon Databook provides a detailed overview of country-level data and insights on the Canada in vitro diagnostics quality control market , including forecasts for subscribers. This country databook contains high-level insights into Canada in vitro diagnostics quality control market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account